← Back to Clinical Trials
Recruiting NCT07441343

NCT07441343 Effects of Polyphenol Supplementation and Exercise on Physical Performance in Older Adults

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07441343
Status Recruiting
Phase
Sponsor Dr. Chris McGlory, PhD
Condition Sarcopenia
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2025-09-01
Primary Completion 2026-06

Eligibility & Interventions

Sex All sexes
Min Age 60 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Polyphenol Rich-ExtractMaltodextrin (Placebo)Resistance Band-Based & Aerobic Stationary Cycling Exercise

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2025-09-01 with a primary completion date of 2026-06.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

After approximately age 40 years, individuals experience a natural loss of muscle mass, strength, and physical function that is linked to higher risks of falls, disability, loss of independence, and mortality. These losses can also be a precursor to the development of frailty, which includes factors beyond impaired physical function such as cognitive impairment, psychological disorder, increased likelihood of hospitalization, need of long term-care, and mortality. Structured exercise-encompassing both resistance and aerobic training-is widely recognized as an effective lifestyle intervention for improving muscle health, cardiovascular capacity, and overall physical function in older adults. However, aging is accompanied by chronically elevated systemic inflammation, and although exercise remains highly beneficial, older adults exhibit a heightened inflammatory response to training and a diminished capacity for post-exercise recovery. Polyphenols, a group of naturally occurring bioactive compounds, have been shown to possess both anti-inflammatory and antioxidant benefits, positively impacting recovery and health. Polyphenol supplementation, particularly when paired with structured exercise, may elicit synergistic improvements in physical performance through combined effects on oxidative stress, inflammation, and muscle recovery, making polyphenols a compelling adjunct strategy for mitigating sarcopenia. In pursuit of refining strategies that support healthy aging and preserve functional capacity in older adults, this study aimed to determine the feasibility of implementing a 12-week resistance and aerobic exercise program combined with dietary supplementation in older adults. Participants will either consume a polyphenol blend or a placebo control of maltodextrin daily whilst undergoing 12 weeks of supervised resistance and aerobic exercise. Additionally, this study will test the hypothesis that polyphenol supplementation will augment the exercise-induced improvements in physical function and muscle health. Further, exploratory analyses of skeletal muscle biopsy and venous plasma samples will aid in elucidating the potential geroprotective effects of polyphenols at both cellular and molecular levels.

Eligibility Criteria

Inclusion Criteria: * Female or Male * Age \> 60y * Non-Smoking * English Speaking Exclusion Criteria: * Self-reported highly trained individual (training \>3x/week for a specific sport with the goal to compete at a high level) * BMI \< 18.5 * Uses insulin to control blood glucose levels * Any medical, orthopaedic, or psychiatric condition that would be comprise ability to comply with study requirements * Regular user of anti-inflammatory and/or analgesic medication * History of neuromuscular disorder or muscle/bone wasting disease * Determined not ready for exercise by the CSEP GAQ * Use of medication known to affect protein metabolism * Family history of thrombosis, platelet or coagulation disorders, or antiplatelet therapy * Use of anticoagulant medication * Personal or family history of clotting disorder or deep vein thrombosis

Contact & Investigator

Central Contact

Chris McGlory, PhD

✉ chris.mcglory@queensu.ca

📞 613-533-6000

Frequently Asked Questions

Who can join the NCT07441343 clinical trial?

This trial is open to participants of all sexes, aged 60 Years or older, studying Sarcopenia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07441343 currently recruiting?

Yes, NCT07441343 is actively recruiting participants. Contact the research team at chris.mcglory@queensu.ca for enrollment information.

Where is the NCT07441343 trial being conducted?

This trial is being conducted at Kingston, Canada.

Who is sponsoring the NCT07441343 clinical trial?

NCT07441343 is sponsored by Dr. Chris McGlory, PhD. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology